Oct 17, 2023, 01:38
Pashtoon Kasi: Our work on the use of BOT/BAL in the neoadjuvant setting for patients with advanced colon and rectal cancer
Quoting Pashtoon Kasi, Director of Colon Cancer Research at the Weill Cornell Medicine, on X/Twitter:
“Our work on the use of BOT/BAL in the neoadjuvant setting for patients with advanced colon and rectal cancer. Full open access version & visual abstract now available at Oncogene journal. Detailed results coming soon. Hope for this to become an option for our patients.”
For the video attached to the post click here.
Source: Pashtoon Kasi/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12